Fig. 5

ASC sup treatment decreases total and OVA-specific IgE and IgG1 expression. The mice serum was diluted (as indicated) in PBS, for measurement of OVA-specific IgE (1:40), IgG1 (1: 10⁵), and IgG2a (1:10⁵) levels by ELISA. (PBS; serum from PBS-treated mice, OVA; serum from OVA-Alum-induced airway inflammation mice, con sup + OVA; serum from OVA-Alum-induced airway inflammation mice with con sup treatment, ASC; sup + OVA serum from OVA-Alum-induced airway inflammation mice with ASC sup treatment. ^* p < 0.05, ^** p < 0.01, ^*** p < 0.001, n = 5 mice per group, experiments were performed in triplicate)